| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1086107826 |
| P356 | DOI | 10.1007/S10792-017-0594-3 |
| P698 | PubMed publication ID | 28639085 |
| P50 | author | Aleksei K Erdiakov | Q88365054 |
| P2093 | author name string | Svetlana A Gavrilova | |
| Marina V Tikhonovich | |||
| P2860 | cites work | Proliferative vitreoretinopathy: an overview | Q77144020 |
| A new model of proliferative vitreoretinopathy | Q77372438 | ||
| Interferon-gamma suppresses cyclooxygenase-2 promoter activity by inhibiting C-Jun and C/EBPbeta binding | Q80447561 | ||
| Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study | Q83979014 | ||
| A look at autoimmunity and inflammation in the eye | Q24623065 | ||
| Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study | Q24673031 | ||
| Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. | Q28583917 | ||
| Characterization of cytokine responses to retinal detachment in rats. | Q33254385 | ||
| Predicting visual outcome following retinectomy for retinal detachment | Q33343917 | ||
| Pars plana vitrectomy with and without triamcinolone acetonide assistance in pseudophakic retinal detachment complicated with proliferative vitreoretinopathy | Q33654421 | ||
| Midterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathy | Q33819634 | ||
| Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration | Q33959113 | ||
| Resolution, the grail for healthy ocular inflammation | Q34126362 | ||
| A mouse model of proliferative vitreoretinopathy induced by dispase | Q34161630 | ||
| Epidemiology of epiretinal membrane in a large cohort of patients with uveitis | Q34616405 | ||
| Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology | Q34724376 | ||
| Immune mechanisms of Concanavalin A model of autoimmune hepatitis | Q35670435 | ||
| The pathophysiologic role of cyclo-oxygenases in the eye. | Q37114769 | ||
| Autoimmune uveitis: clinical, pathogenetic, and therapeutic features. | Q38395263 | ||
| Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences | Q38553849 | ||
| Action of the bacterial neutral protease, dispase, on cultured cells and its application to fluid suspension culture with a review on biomedical application of this protease. | Q39659743 | ||
| Sterile endophthalmitis rates and particle size analyses of different formulations of triamcinolone acetonide | Q40821399 | ||
| Effects of triamcinolone acetonide on vessels of the posterior segment of the eye. | Q42464404 | ||
| Positive feedback regulation of COX-2 expression by prostaglandin metabolites | Q42478025 | ||
| Functional and anatomical remodeling in human retinal detachment. | Q42503235 | ||
| Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac | Q44667636 | ||
| Preventing retinal detachment-associated photoreceptor cell loss in Bax-deficient mice. | Q44743326 | ||
| Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo). | Q44967479 | ||
| Protective effect of lornoxicam on development of myocardial infarction in rats under conditions of ischemia and ischemia-reperfusion | Q46201542 | ||
| Concanavalin A-induced posterior subcapsular cataract: a new model of cataractogenesis. | Q46325565 | ||
| Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis. | Q46932428 | ||
| Activation of neural progenitor cells in human eyes with proliferative vitreoretinopathy | Q48705867 | ||
| Expression of cyclooxygenases and trophic and growth factors in epiretinal membranes at late stages of proliferative vitreoretinopathy. | Q51598482 | ||
| Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. | Q52518081 | ||
| Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. | Q52518083 | ||
| Pharmacokinetics and efficacy of Bioerodible Dexamethasone implant in Concanavalin A-induced uveitic cataract rabbit model. | Q52651217 | ||
| P433 | issue | 4 | |
| P921 | main subject | proliferative vitreoretinopathy | Q7249608 |
| P304 | page(s) | 1365-1378 | |
| P577 | publication date | 2017-06-21 | |
| P1433 | published in | International Ophthalmology | Q15763839 |
| P1476 | title | Nonsteroid anti-inflammatory therapy suppresses the development of proliferative vitreoretinopathy more effectively than a steroid one | |
| P478 | volume | 38 |
| Q90479123 | GSK3β inhibits epithelial-mesenchymal transition via the Wnt/β-catenin and PI3K/Akt pathways |
| Q90699428 | Icariin affects cell cycle progression and proliferation of human retinal pigment epithelial cells via enhancing expression of H19 |
| Q89902210 | Inflammatory mediators of proliferative vitreoretinopathy: hypothesis and review |
| Q90707319 | Upregulated CD200 in pre-retinal proliferative fibrovascular membranes of proliferative diabetic retinopathy patients and its correlation with vascular endothelial growth factor |
Search more.